This marks Sidekick's accelerated innovation
in digital therapeutics for improved patient outcomes
AMSTERDAM, June 18,
2024 /PRNewswire/ -- Sidekick Health, a global leader
in digital health innovation, today announced the acquisition of
PINK!, a pioneering digital health company specializing in cancer
support and women's health. This strategic move enhances Sidekick
Health's portfolio and strengthens its position in the digital
therapeutics market.
This acquisition brings with it PINK! Coach, the only
permanently listed prescription digital therapeutic (PDT) for
breast cancer within Germany's
regulated nationwide DiGA (Digitale Gesundheitsanwendungen)
formulary. PINK! Coach is a digital application developed to
enhance health-related quality of life and health literacy, while
also addressing the psychological, psychosomatic, and physical
effects of breast cancer. To achieve a lasting improvement in
quality of life and health, PINK! Coach focuses on gradually and
sustainably changing the user's health-related behaviors.
Sidekick Health's acquisition strengthens their position at the
forefront of the industry, further unlocking opportunities to scale
the highest-quality, medical-grade digital therapeutics to patients
and deploy them within the leading Healthcare and Life Sciences
companies in the US and EU.
Sidekick has been growing at an 80% compound annual growth rate
and currently works with five of the world's twenty largest
healthcare companies to reshape the digital health landscape. Its
products are prescribed on a regular basis by over 13,000
physicians. Within the US payer landscape, the company is notably
collaborating with one of the largest health insurers, and is live
with partners in Medicare, Medicaid and employer populations across
the country. In the pharmaceutical sector, it has cultivated
strategic partnerships with industry giants like Eli Lilly and
Pfizer, with multiple partnerships across the US and Europe.
Dr. Tryggvi Thorgeirsson, Co-founder and CEO of Sidekick
Health, commented on the acquisition:
"The acquisition of PINK! aligns perfectly with our mission to
transform healthcare globally through digital innovation. By
integrating PINK!'s cutting-edge breast cancer prescription digital
therapeutic into our portfolio, we are ready to offer an even more
comprehensive portfolio of digital therapeutics to patients –
including further expansion opportunities within women's health and
oncology. We are particularly excited to work with Prof. Dr. Pia
Wülfing and her impressive team, whose dedication and expertise in
breast cancer support and women's health have been truly
inspirational. Pia's leadership at PINK! has created a strong
foundation that we are eager to build upon."
Prof. Dr. Pia Wülfing, founder and CEO of PINK!, shared her
thoughts:
"Joining forces with Sidekick Health represents an exciting new
chapter for PINK!. Together, we can leverage our combined expertise
to make a profound impact on the lives of patients with breast
cancer in Europe, North America, and beyond. This step will
enable us to expand the reach of our digital health solutions,
including with Sidekick's partners, and continue to offer patients
innovative solutions, providing better support and care for people
living with cancer."
The combined expertise of both companies will create new
opportunities for innovation in digital therapeutics and expand the
range and clinical impact of conditions addressed by Sidekick's
patient-centric programs. The integration will also see PINK!'s
team joining Sidekick Health, enhancing the company's capabilities
and fostering collaboration for future product development.
This acquisition follows Sidekick's successful acquisition
of aidhere in October 2023,
which marked Sidekick's entry into the prescription digital
therapeutics market with the addition of aidhere's zanadio app for
obesity management. zanadio is one of the most successful PDTs
launched to date in the world, with over 75,000 prescriptions by
over 13,000 prescribing healthcare professionals. The addition of
PINK! further solidifies Sidekick's commitment to expanding its
digital therapeutic offerings and enhancing patient care through
innovative digital solutions across multiple geographies.
About Sidekick Health
Sidekick Health is a global
healthcare company that works with partners to digitize and
fundamentally improve how care is managed and delivered, making
healthcare more impactful, equitable, and efficient. We work with a
quarter of the global top-20 healthcare companies across insurers,
life sciences, and prescription digital therapeutics industries to
deploy single and multi-condition care journeys for more than 20
therapeutic areas.
Learn more about our work and our innovative partnerships
at sidekickhealth.com/research and
sidekickhealth.com/media.
About PINK!
PINK! operates a physician-led online platform for breast cancer
patients, offering digital therapeutics. The HealthTech startup
from Hamburg developed PINK!
Coach, the first and only breast cancer app permanently approved as
a DiGA ("app on prescription"). This app serves as a digital
companion for breast cancer patients, providing
scientifically-based medical information and guidance. It helps
patients implement beneficial behaviors through daily
individualized goals in areas such as exercise, nutrition, and
mental health, aiming to reduce side effects like psychological
distress and fatigue, and to improve quality of life. A
psycho-oncological online course further complements PINK!'s
offerings.
Founded in 2020 by gynecologist Prof. Dr. Pia Wülfing and
Katharina von Trotha, PINK!
currently employs 27 staff members and collaborates with many
renowned medical and scientific experts. More information is
available at: https://pink-brustkrebs.de/
Media contact
For press inquiries or additional information, please contact
Serene Touma at press@sidekickhealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sidekick-health-expands-oncology-and-womens-health-portfolio-with-acquisition-of-pink-in-germany-302175468.html
SOURCE Sidekick Health